Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Saura C, Hlauschek D, Oliveira M, Zardavas D, Jallitsch-Halper A, de la Peña L, Nuciforo P, Ballestrero A, Dubsky P, Lombard JM, Vuylsteke P, Castaneda CA, Colleoni M, Santos Borges G, Ciruelos E, Fornier M, Boer K, Bardia A, Wilson TR, Stout TJ, Hsu JY, Shi Y, Piccart M, Gnant M, Baselga J, de Azambuja E. Saura C, et al. Among authors: zardavas d. Lancet Oncol. 2019 Sep;20(9):1226-1238. doi: 10.1016/S1470-2045(19)30334-1. Epub 2019 Aug 8. Lancet Oncol. 2019. PMID: 31402321 Clinical Trial.
Emerging targeted agents in metastatic breast cancer.
Zardavas D, Baselga J, Piccart M. Zardavas D, et al. Nat Rev Clin Oncol. 2013 Apr;10(4):191-210. doi: 10.1038/nrclinonc.2013.29. Epub 2013 Mar 5. Nat Rev Clin Oncol. 2013. PMID: 23459626 Review.
Progress in adjuvant systemic therapy for breast cancer.
Pondé NF, Zardavas D, Piccart M. Pondé NF, et al. Among authors: zardavas d. Nat Rev Clin Oncol. 2019 Jan;16(1):27-44. doi: 10.1038/s41571-018-0089-9. Nat Rev Clin Oncol. 2019. PMID: 30206303 Review.
Neoadjuvant therapy for breast cancer.
Zardavas D, Piccart M. Zardavas D, et al. Annu Rev Med. 2015;66:31-48. doi: 10.1146/annurev-med-051413-024741. Epub 2014 Oct 27. Annu Rev Med. 2015. PMID: 25386936 Review.
Clinical management of breast cancer heterogeneity.
Zardavas D, Irrthum A, Swanton C, Piccart M. Zardavas D, et al. Nat Rev Clin Oncol. 2015 Jul;12(7):381-94. doi: 10.1038/nrclinonc.2015.73. Epub 2015 Apr 21. Nat Rev Clin Oncol. 2015. PMID: 25895611 Review.
62 results